EX-21.1 6 ex-2101.htm

Exhibit 21.1


LIST OF SUBSIDIARIES
       
  Principal subsidiary/undertaking   Jurisdiction of incorporation
       
  Shire Pharmaceuticals Group plc   England and Wales
  Shire Pharmaceuticals Limited   England and Wales
  Shire Pharmaceutical Development Limited   England and Wales
  Shire Pharmaceutical Contracts Limited   England and Wales
  Shire Pharmaceuticals Ireland Limited   Ireland
  Shire International Licensing BV   Netherlands
  Shire Deutschland GmbH & Co. KG   Germany
  Shire France S.A.   France
  Shire Italia SpA   Italy
  Shire Pharmaceuticals Iberica S.L.   Spain
  Shire Finance Limited   Cayman Islands
  Shire US Inc.   State of New Jersey, USA
  Shire Pharmaceuticals Inc.   State of Delaware, USA
  Shire LLC   State of Kentucky, USA
  Shire Pharmaceuticals US Development Inc.   State of Maryland, USA
  Shire Development Inc.   State of Delaware, USA
  Shire Regulatory Inc.   State of Delaware, USA
  Shire US Manufacturing Inc.   State of Maryland, USA
  Shire BioChem Inc.   Canada
  Transkaryotic Therapies, Inc.   State of Delaware, USA
  TKT Europe AB   Sweden
       
  All subsidiary undertakings of Shire plc are beneficially owned (directly or indirectly) as to 100% and are all consolidated in the consolidated financial statements of Shire plc.